The role of ocular blood flow in OAG

Article

Ocular blood flow alterations and previous visual field damage may play an important role in visual field progression in open angle glaucoma (OAG), according to Antonio Martinez and colleagues from the Instituto Gallego de Oftalmologia, Spain.

Ocular blood flow alterations and previous visual field damage may play an important role in visual field progression in open angle glaucoma (OAG), according to Antonio Martinez and colleagues from the Instituto Gallego de Oftalmologia, Spain.

All OAG patients recruited or referred to one centre between January and July 2001 were examined. Kaplan-Meier survival analysis was used to estimate visual field progression and variables considered to be possible risk factors were evaluated using the one-way analysis of variance (ANOVA) and Cox proportional hazards regression analysis.

A total of 40 patients were evaluated during the trial period. Mean time to progression was 37.88 months, 95% confidence interval 33.10-42.65. Sixteen patients (40%) showed visual field progression. Significant risk factors included pattern standard deviation, end-diastolic velocity in the ophthalmic artery and resistance index in the ophthalmic artery.

The results suggest that ocular blood flow alterations may play a central role in the visual field progression in OAG patients.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
© 2025 MJH Life Sciences

All rights reserved.